Cargando…
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
COVID-19–associated morbidity and mortality have been attributed to a pathologic host response. Two divergent hypotheses have been proposed: hyperinflammatory cytokine storm; and failure of host protective immunity that results in unrestrained viral dissemination and organ injury. A key explanation...
Autores principales: | Remy, Kenneth E., Mazer, Monty, Striker, David A., Ellebedy, Ali H., Walton, Andrew H., Unsinger, Jacqueline, Blood, Teresa M., Mudd, Philip A., Yi, Daehan J., Mannion, Daniel A., Osborne, Dale F., Martin, R. Scott, Anand, Nitin J., Bosanquet, James P., Blood, Jane, Drewry, Anne M., Caldwell, Charles C., Turnbull, Isaiah R., Brakenridge, Scott C., Moldwawer, Lyle L., Hotchkiss, Richard S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526441/ https://www.ncbi.nlm.nih.gov/pubmed/32687484 http://dx.doi.org/10.1172/jci.insight.140329 |
Ejemplares similares
-
Interleukin-7 Reverses Lymphopenia and Improves T-Cell Function in Coronavirus Disease 2019 Patient With Inborn Error of Toll-Like Receptor 3: A Case Report
por: Mazer, Monty B., et al.
Publicado: (2021) -
In Vitro–Administered Dexamethasone Suppresses T Cell Function With Reversal by Interleukin-7 in Coronavirus Disease 2019
por: Mazer, Monty B., et al.
Publicado: (2021) -
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
por: Daix, Thomas, et al.
Publicado: (2023) -
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm
por: Mudd, Philip A., et al.
Publicado: (2020) -
IL-7 Immunotherapy in a Nonimmunocompromised Patient With Intractable Fungal Wound Sepsis
por: Turnbull, Isaiah R, et al.
Publicado: (2021)